Latest Asx News

Astral Resources has updated its Mandilla Gold Project resource to 1.43 million ounces and completed the acquisition of Maximus Resources, positioning itself for a major development milestone with a Pre-Feasibility Study due in June 2025.

Great Divide Mining Ltd has taken a decisive step from explorer to gold producer by securing a farm-in agreement for the Adelong Gold Project and raising $2.05 million to fund production restart and exploration activities.

Wisr Limited reported a robust Q3FY25 with loan originations surging 115% year-on-year and a second consecutive quarter of loan book growth, prompting an upgrade to its FY25 loan origination guidance.

FireFly Metals reports robust March quarter results, highlighting significant drilling success at its Green Bay Copper-Gold Project and a well-funded position to advance large-scale mining studies.

Lark Distilling Co. reported a robust Q3FY25 with net sales rising 31% to $4.3 million, driven by growth in travel retail, ecommerce, and exclusive whisky releases. The company also progressed its Pontville distillery redevelopment and maintained positive operating cash flow.

Top End Energy has completed its strategic acquisition of Serpentine Energy, significantly expanding its natural hydrogen footprint in Kansas and advancing towards its first well drilling, while also progressing exploration in Australia’s Northern Territory.

Island Pharmaceuticals has completed dosing in the Phase 2b cohort of its dengue fever trial, with pharmacokinetic targets met and top-line results expected next month. The company also strengthened its balance sheet by raising $1.94 million through option exercises.

PeopleIn Limited reported a $6.3 million Q3 FY25 EBITDA, down from $6.9 million last year, affected by severe weather in Queensland. Strong cash flow helped reduce debt, underscoring resilience despite ongoing trading challenges.

GreenTech Metals has reported promising drilling results at its Whundo Copper-Zinc project, confirming significant down plunge mineralisation and advancing resource expansion. Meanwhile, it has formed a 50/50 lithium joint venture with Artemis Resources, creating the largest lithium exploration package in the West Pilbara.

CurveBeam AI reported a robust 40% increase in purchase orders during Q3 FY25 and secured a non-binding A$18 million vendor financing term sheet, positioning the company for cashflow positivity in Q4.

CurveBeam AI Limited reported a $4.367 million net operating cash outflow for Q3 2025 but anticipates a significant improvement in cash flow driven by device installations and customer receipts, with no immediate plans for capital raising.

Tryptamine Therapeutics has secured a landmark agreement with Swinburne University to initiate the first clinical trial of its IV-infused psilocin formulation TRP-8803 for Binge Eating Disorder, aiming to build on promising Phase 2a data.